CSEIX | FRLCX | CSEIX / FRLCX | |
Total Expense Ratio | 1.10 | 1.93 | 57% |
Annual Report Gross Expense Ratio | 1.10 | 2.02 | 54% |
Fund Existence | 28 years | 26 years | - |
Gain YTD | 3.749 | 1.684 | 223% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 847M | 980% |
Annual Yield % from dividends | 2.45 | 2.51 | 97% |
Returns for 1 year | -4.58 | -9.74 | 47% |
Returns for 3 years | 26.85 | -1.75 | -1,538% |
Returns for 5 years | 35.08 | -7.50 | -468% |
Returns for 10 years | 63.15 | -23.27 | -271% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 56.96 | 1.50 | +2.70% |
ProShares Ultra Nasdaq Biotechnology | |||
CRF | 7.98 | 0.06 | +0.72% |
Cornerstone Total Return Fund | |||
AVS | 10.44 | 0.06 | +0.58% |
Direxion Daily AVGO Bear 1X Shares | |||
ASMG | 21.13 | 0.03 | +0.14% |
Leverage Shares 2X Long Asml Daily ETF | |||
UEVM | 54.53 | -0.08 | -0.15% |
VictoryShares Emerging Mkts Val MomtETF |